Structure of the hirugen and hirulog 1 complexes of alpha-thrombin. J Mol Biol. 1991;221(4):1379-1393. 220. Witting JI, Bourdon P, Maraganore JM, Fenton JW II. Hirulog-1 and -B2 thrombin speci city. Biochem J. 1992;287(pt 2):663-664. 221. Fox I, Dawson A, Loynds P, et al. Anticoagulant activity of Hirulog, a direct thrombin inhibitor, in humans. Thromb Haemost. 1993;69(2):157-163. 222. Robson R. The use of bivalirudin in patients with renal impairment. J Invasive Cardiol. 2000;12(suppl F):33F-6. 223. White HD. Pharmacological and clinical pro le of biva- lirudin in the treatment of patients with acute coronary syndrome. Expert Opin Drug Metab Toxicol. 2009;5(5): 529-538. 224. Banner DW, Hadv ry P. Inhibitor binding to thrombin: x-ray crystallographic studies. Adv Exp Med Biol. 1993;340: 27-33. 188. Casele HL, Laifer SA. Prospective evaluation of bone den- sity in pregnant women receiving the low molecular weight heparin enoxaparin sodium. J Matern Fetal Med. 2000;9(2): 122-125. 189. Pettil V, Leinonen P, Markkola A, Hiilesmaa V, Kaaja R. Postpartum bone mineral density in women treated for thromboprophylaxis with unfractionated heparin or LMW heparin. Thromb Haemost. 2002;87(2):182-186. 190. Wawrzysnka L, Tomkowski WZ, Przedlacki J, Hajduk B, Torbicki A. Changes in bone density during long-term administration of low-molecular-weight heparins or aceno- coumarol for secondary prophylaxis of venous thrombo- embolism. Pathophysiol Haemost Thromb. 2003;33(2): 64-67. 191. Lefkou E, Khamashta M, Hampson G, Hunt BJ. Review: Low-molecular-weight heparin-induced osteoporosis and osteoporotic fractures: a myth or an existing entity? Lupus. 2010;19(1):3-12. 192. Choay J, Lormeau JC, Petitou M, Sina P, Fareed J. Struc- tural studies on a biologically active hexasaccharide obtained from heparin. Ann N Y Acad Sci. 1981;370:644-649. 193. Thunberg L, B ckstr m G, Lindahl U. Further character- ization of the antithrombin-binding sequence in heparin. Carbohydr Res. 1982;100:393-410. 194. Choay J. Biologic studies on chemically synthesized penta- saccharide and tetrasaccharide fragments. 